SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Dinosol

Dinosol is trending, with community members expressing excitement and touting it as the next big Solana project. Amidst the bullish sentiment, some users are raising concerns about potential risks and comparing it to other speculative coins, while others are doing technical analysis.

Litecoin is a peer-to-peer cryptocurrency created by Charlie Lee. It was created based on the Bitcoin protocol but differs in terms of the hashing algorithm used. Litecoin uses the memory intensive Scrypt proof of work mining algorithm. Scrypt allows consumer-grade hardware such as GPU to mine those coins.  Why Litecoin? Litecoin is a cryptocurrency that has evolved from Bitcoin after its own popularity in the industry, this alternative, or ‘altcoin’ has emerged to allow investors to diversify their digital currency package, according to Investopedia. Litecoin is one of the most prominent altcoins and was created by former Google employee and Director of Engineering at Coinbase, Charlie Lee. Litecoin was the first to alter Bitcoin and the most significant difference is that it takes 2.5 minutes for Litecoin to generate a block, or transaction, in comparison to Bitcoin's 10 minutes.  ‘While this matters little to traders, miners who use hardware to run Bitcoin's network cannot switch over to Litecoin. This keeps bigger mining conglomerates away from Litecoin because they cannot easily optimize their profits by swapping to another coin, contributing to a more decentralized experience. Litecoin also has bigger blocks, and more coins in circulation, making it more affordable and swift when transacting,’ Investopedia explained.  As explained above, Litecoin can transact a lot faster than Bitcoin, but there are also a number of other characteristics that investors need to know before trading. Litecoin can handle higher volumes of transactions because of the capability of transacting faster and if Bitcoin attempted to transact on the scale of its altcoin, a code update would be needed. However, Litecoin’s blocks would be larger, but with more ‘orphaned blocks'. The faster block time of litecoin reduces the risk of double spending attacks - this is theoretical in the case of both networks having the same hashing power.  Litecoin Technical Details: The transaction confirmation time taken for Litecoin is about 2.5 minutes on average (as compared to Bitcoin's 10 minutes). The Litecoin network is scheduled to cap at 84 million currency units.   Litecoin has inspired many other popular alternative currencies (eg. Dogecoin) because of its Scrypt hashing algorithm in order to prevent ASIC miners from mining those coins. However it is said that by the end of this year, Scrypt ASIC will enter the mass market.

Litecoin

Litecoin is trending as the community discusses potential bullish formations, including a possible breakout against Bitcoin. Positive sentiment is building, with some anticipating a Santa rally and highlighting Litecoin's real-world utility through Flexa-powered crypto acceptance at major retailers. Comparisons to other crypto projects and traditional assets like Nvidia are also circulating among traders.

Duke Energy Corp. engages in the distribution of natural gas and energy-related services. It operates through the following segments: Electric Utilities and Infrastructure, Gas Utilities and Infrastructure, and Other. The Electric Utilities and Infrastructure segment conducts operations in regulated electric utilities in the Carolinas, Florida and the Midwest. The Gas Utilities and Infrastructure segment focuses on Piedmont, natural gas local distribution companies in Ohio and Kentucky, and natural gas storage and midstream pipeline investments. The Other segment includes interest expense on holding company debt, unallocated corporate costs, and Bison which is a wholly owned captive insurance company. The company was founded on April 30, 1904 and is headquartered in Charlotte, NC.

Duke Energy Corp.

Duke Energy ($DUK) is trending amid discussions about infrastructure investments and clean energy initiatives, with recent reports highlighting the company's commitment to grid modernization and renewable energy projects. Community members are weighing the potential for long-term growth and dividend stability against concerns about debt levels and the impact of rising interest rates. Recent analyst activity and target price adjustments have also contributed to the increased attention on the stock.

Terra 2.0 which will assume the Terra name is a new blockchain launched by Terraform Labs as part of the passing of governance proposal 1623.  The Terra protocol is a decentralized and open-source public blockchain protocol. Luna is the Terra protocol’s native staking token used for governance and mining.  Users stake Luna to validators who record and verify transactions on the blockchain in exchange for rewards from transaction fees.  The Terra 2.0 chain will not have a stablecoin and holders of the old Terra Classic chain will be airdropped new Luna native coins. In the plan, developers of the Terra ecosystem are to migrate and deploy their dapps on the new blockchain.

Terra 2.0

LUNA is trending amid discussions around potential ecosystem developments and speculative price movements. Community members are weighing in on the possibility of a comeback, while some are drawing comparisons to past events and other tokens. The conversation also includes mentions of related tokens and potential trading strategies.

DEGEN is a reward token for Farcaster users, born from meme culture. It features a unique tipping system that allows the community to reward high-quality content creators. DEGEN also powers the Degen Chain, one of the pioneering Layer 3s launched on Base. Known as the “Las Vegas of blockchains,” it provides a platform for building and using Degen apps, offering a space for fun, innovation, and community-driven experiences.

League of Degens 

DEGEN is trending as community members discuss its potential, upcoming app launch, and possible Binance listing; however, some express concerns about price stagnation and unfulfilled promises like token burns. Bullish sentiment focuses on DEGEN's strong community, potential AI integrations, and predictions of significant price increases, while bearish voices cite concerns about current price action.

Immix Biopharma, Inc. operates as a biopharmaceutical company that engages in the development of therapies for cancer and inflammatory diseases. The company was founded by Ilya Rachman, Sean Senn, and Vladimir Torchilin in 2012 and is headquartered in Los Angeles, CA.

Immix Biopharma Inc

Immix Biopharma is trending as discussions revolve around its BCMA-directed CAR-T therapy and potential expansion into autoimmune diseases, following promising data in systemic sclerosis, lupus, and inflammatory myopathies. The community is focused on the implications of this data for IMMX's NXC-201 and its potential to enter a larger market beyond hematologic cancers. Some investors speculate on potential valuation and buyout scenarios given the recent developments and upcoming ASH conference.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: Cybersecurity, Internet of Things (IoT), and Licensing and Other. The Cybersecurity segment includes the brand Cylance, BlackBerry Spark, AtHoc, and SecuSUITE. The IoT segment focuses on software licenses, support, maintenance, and professional services. The Licensing and Other segment involves the intellectual property licensing arrangements and settlement awards. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is trending as the community discusses the potential impact of QNX technology, particularly within automotive and IoT sectors. Investors are closely watching technical indicators like golden crosses and wedge formations, interpreting them as bullish signals. Optimism is further fueled by upcoming earnings and anticipation of significant revenue from QNX, with some suggesting a connection between BlackBerry and Nvidia.

The Sandbox is a community-driven platform where creators can monetize voxel ASSETS and gaming experiences on the blockchain.  SAND is the utility token used throughout The Sandbox ecosystem as the basis of transactions and interactions. It is an ERC-20 utility token built on the Ethereum blockchain. There is a finite supply of 3,000,000,000 SAND.

The Sandbox

SAND is trending as the gaming sector heats up, with community members discussing potential rallies and revisiting the metaverse narrative. Bullish sentiment is fueled by gaming ecosystems and talk of a potential 300% pump from current levels, while some traders eye previous highs. Community members are closely watching gaming tokens as a whole.

Terra is a decentralized financial payment network that rebuilds the traditional payment stack on the blockchain. Luna is the reserve currency of the Terra platform. It has three core functions: i) mine Terra transactions through staking, ii) ensure the price stability of Terra stablecoins and iii) provide incentives for the platform’s blockchain validators.

Terra Luna Classic

Terra Luna Classic is trending as community members discuss potential buy-the-dip opportunities and speculate on the impact of exchange delistings and Binance's involvement. Some traders are highlighting increased volume and the potential for a short squeeze, while others are focused on the project's long-term recovery and token burning mechanisms. Community members are also closely monitoring developments around Do Kwon and their potential implications for LUNC.

Innodata, Inc. is a data engineering company, which engages in providing artificial intelligence software platforms and management of its services. It operates through the following business segments: Digital Data Solutions (DDS), Synodex, and Agility. The DDS segment combines deep neural networks and human expertise in multiple domains to make unstructured information useable. The Synodex segment enables clients in the insurance and healthcare sectors to transform medical records into useable digital data and to apply technologies to the digital data to augment decision support. The Agility segment provides tools and related professional services that enable public relations and communications professionals to discover influencers, amplify messages, monitor coverage, and measure the impact of campaigns. The company was founded by Todd H. Solomon in 1988 and is headquartered in Ridgefield Park, NJ.

Innodata Inc

Innodata is trending due to speculation surrounding a potential partnership with Lockheed Martin or Palantir, fueled by CEO Jack's hints of a "game changer" announcement before year-end, specifically related to US defense AI. Community talking points revolve around the potential partner's market leadership and the transformative impact on Innodata's growth, with some drawing parallels to past successful partnerships in the AI sector and anticipating a significant rally.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Protagonist And Takeda Report 52-Week Rusfertide Data In Polycythemia Vera

(RTTNews) - Protagonist Therapeutics, Inc. (PTGX) and Takeda (TAK) announced new 52-week results from the pivotal Phase 3 VERIFY study of rusfertide in patients with polycythemia vera (PV). The data...

Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera

Protagonist Therapeutics, Inc. (Protagonist) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients...

Protagonist Therapeutics, Inc. $PTGX Shares Purchased by American Century Companies Inc.

American Century Companies Inc. boosted its position in shares of Protagonist Therapeutics, Inc. (NASDAQ:PTGX - Free Report) by 18.7% during the second quarter, according to the company in its most...

Protagonist Therapeutics, Inc. $PTGX Shares Bought by Creative Planning

Creative Planning grew its position in Protagonist Therapeutics, Inc. (NASDAQ:PTGX - Free Report) by 74.3% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange...

Protagonist Therapeutics, Inc. $PTGX Shares Acquired by Universal Beteiligungs und Servicegesellschaft mbH

Universal Beteiligungs und Servicegesellschaft mbH increased its stake in shares of Protagonist Therapeutics, Inc. (NASDAQ:PTGX - Free Report) by 864.8% in the second quarter, according to the...

Protagonist Therapeutics Reaches Analyst Target Price

In recent trading, shares of Protagonist Therapeutics Inc (Symbol: PTGX) have crossed above the average analyst 12-month target price of $89.77, changing hands for $89.86/share. When a stock reaches...

Intech Investment Management LLC Acquires 2,971 Shares of Protagonist Therapeutics, Inc. $PTGX

Intech Investment Management LLC lifted its holdings in Protagonist Therapeutics, Inc. (NASDAQ:PTGX - Free Report) by 9.6% in the second quarter, according to the company in its most recent filing...

Envestnet Asset Management Inc. Grows Position in Protagonist Therapeutics, Inc. $PTGX

Envestnet Asset Management Inc. raised its stake in Protagonist Therapeutics, Inc. (NASDAQ:PTGX - Free Report) by 43.2% in the second quarter, according to the company in its most recent disclosure...

Protagonist Therapeutics, Inc. $PTGX Stock Holdings Trimmed by Aviva PLC

Aviva PLC lowered its position in shares of Protagonist Therapeutics, Inc. (NASDAQ:PTGX - Free Report) by 28.5% during the 2nd quarter, according to its most recent disclosure with the Securities...

135,050 Shares in Protagonist Therapeutics, Inc. $PTGX Purchased by Nan Fung Trinity HK Ltd.

Nan Fung Trinity HK Ltd. purchased a new stake in Protagonist Therapeutics, Inc. (NASDAQ:PTGX - Free Report) in the second quarter, according to its most recent Form 13F filing with the SEC. The...

Protagonist Therapeutics, Inc. a clinical-stage biopharmaceutical company, which engages in discovering and developing peptide-based therapeutic drugs to address unmet medical needs. Its product pipeline includes PTG-300, PTG-200, and PN-943. The company was founded by Mark L. Smythe on August 22, 2006 and is headquartered in Newark, CA.

Protagonist Therapeutics Inc

$SOFI

$RDDT

$CVNA

$MSTR

Which stock do you think gets added to the S&amp;P 500 in today’s rebalance?

Stocktwits

Which stock do you think gets added to the S&P 500 in today’s rebalance?

PTGX
Protagonist Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest PTGX News

PTGXProtagonist Therapeutics Inc